Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Evommune Inc. (EVMN) had Return on Investments of 6.81% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$10.00M |
|
$-12.47M |
|
-- |
|
$10.00M |
|
$23.33M |
|
$-13.33M |
|
$0.85M |
|
$-12.47M |
|
$-12.47M |
|
$-12.47M |
|
$-12.47M |
|
$-12.47M |
|
$-12.47M |
|
$-13.33M |
|
$-13.33M |
|
1.54M |
|
1.54M |
|
$-8.07 |
|
$-8.07 |
|
| Balance Sheet Financials | |
$81.94M |
|
$0.97M |
|
$2.60M |
|
$84.54M |
|
$10.42M |
|
-- |
|
$257.26M |
|
$267.68M |
|
$-183.14M |
|
$-183.14M |
|
$-183.14M |
|
1.55M |
|
| Cash Flow Statement Financials | |
$-59.74M |
|
$7.59M |
|
$63.91M |
|
$16.46M |
|
$28.23M |
|
$11.77M |
|
$1.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.87 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-133.28% |
|
-133.28% |
|
-- |
|
-124.75% |
|
-124.75% |
|
$-59.87M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
6.81% |
|
6.81% |
|
-14.76% |
|
|
Return on Investments |
6.81% |
$-117.77 |
|
$-38.75 |
|
$-38.67 |
|